The Impact of <scp>IgG</scp> Fc‐Glycosylation on Disease Dynamics in Primary Sjögren's Disease‐ Insights from the Belgian Sjögren's Syndrome Transition Trial

2024-9-29

Urinary Biomarkers: Toward a Liquid Biopsy for Lupus Nephritis

2024-9-29

Urinary biomarkers associated with pathogenic pathways reflecting histological findings in lupus nephritis

2024-9-24

Erdheim‐Chester disease presenting with palpitations and spondylopathy

2024-9-23

Effectiveness of janus kinase inhibitors compared with biologic disease modifying anti‐rheumatic drugs on pain reduction in rheumatoid arthritis

2024-9-22

Gout Flares As Vascular Red Flags

2024-9-22

Strength Training Is Associated With Less Knee Osteoarthritis: Data From the Osteoarthritis Initiative: comment on the article by Lo et al

2024-9-19

Weight loss after initiating anti‐obesity medications and gout among overweight and obesity individuals: a population‐based cohort study

2024-9-19

Strength Training Associates with Less Symptom and Structure Outcomes for Knee Osteoarthritis

2024-9-19

Efficacy and Safety of Intravenous Secukinumab for the Treatment of Active Psoriatic Arthritis: Results From the Randomized, Placebo‐Controlled Phase <scp>III INVIGORATE</scp>‐2 Study

2024-9-19

Efficacy and Safety of Intravenous Secukinumab in Patients With Active Axial Spondyloarthritis: Results From the Randomized, Placebo‐Controlled, Phase <scp>III INVIGORATE</scp>‐1 Study

2024-9-19

Unraveling The Genetics of Shared Clinical and Serological Manifestations in Systemic Inflammatory Autoimmune Diseases

2024-9-16

<scp>IĸBζ</scp> is a central modulator of inflammatory arthritis pathogenesis

2024-9-15

<scp>TLR7</scp>/8 Activation in Immune Cells and Muscle by <scp>RNA</scp>‐Containing Immune Complexes: Role in Inflammation and the Pathogenesis of Myositis

2024-9-15

Hypoxia Promotes the Expression of <scp>ADAM9</scp> by Tubular Epithelial Cells which Enhances <scp>TGF</scp>‐β1 Activation and Promotes Tissue Fibrosis in Lupus Nephritis

2024-9-15

Short‐term risk of cardiovascular events in people newly diagnosed with gout

2024-9-15

Enhancing intracellular cholesterol efflux in chondrocytes alleviates osteoarthritis progression

2024-9-11

Understanding the role of type I IFN in cutaneous lupus and dermatomyositis: towards better therapeutics

2024-9-11

Erratum

2024-9-10

Emapalumab Use in Patients With Rheumatologic Disease–Associated Hemophagocytic Lymphohistiocytosis in the United States: the <scp>REAL</scp>‐<scp>HLH</scp> Study

2024-9-8

Do Existing <scp>MRI</scp> Definitions of Knee Osteoarthritis Identify Knees That Will Develop Clinically Significant Disease Over Up To 11 Years of Follow‐Up?

2024-9-4

Diversity and epitope spreading of anti‐<scp>RNA</scp> polymerase <scp>III</scp> antibodies in systemic sclerosis: a potential biomarker for skin and lung involvement

2024-9-1

Journal Club

2024-8-26

Relapse prediction in <scp>ANCA</scp>‐associated vasculitis

2024-8-26

Refining Research on Systemic Lupus Erythematosus with Key Considerations

2024-8-26

Mutual amplification of <scp>GLI2</scp>/Hedgehog and <scp>cJUN</scp>/<scp>AP1</scp> signaling in fibroblasts in Systemic Sclerosis (<scp>SSc</scp>) – potential implications for combined therapies

2024-8-26

Issue Information

2024-8-26

In This Issue

2024-8-26

Clinical Connections

2024-8-26

Reply to: Refining Research on Systemic Lupus Erythematosus with Key Considerations

2024-8-26

A large disfiguring nasal mass and progressive dyspnea

2024-8-26

Targeting <scp>CD13</scp>/aminopeptidase N as a novel therapeutic approach for scleroderma fibrosis

2024-8-22

The relationship between ultrasound and physical examination in the assessment of enthesitis in <scp>SpA</scp> patients: results from the <scp>DEUS</scp> multicentre study

2024-8-20

The muscle tissue transcriptome of idiopathic inflammatory myopathy reflects the muscle damage process by monocytes and presence of skin lesions

2024-8-20

Clinical Images: Painless subcutaneous swellings in a middle‐aged man

2024-8-20

Enhanced Type 1 Interferon Signature in Axial Spondyloarthritis Patients Unresponsive to Secukinumab Treatment

2024-8-19

Efficacy versus effectiveness: The <scp>HORIZON</scp> Pivotal Fracture Trial and its emulation in Claims Data

2024-8-11

Novel genetic loci in early‐onset gout derived from whole genome sequencing of an adolescent gout cohort

2024-8-8

<scp>TLR8</scp> is expressed in monocytes in contrast to plasmacytoid dendritic cells and mediates aberrant <scp>IL</scp>‐10 responses in patients with systemic sclerosis (<scp>SSc</scp>)

2024-8-7

Features of Axial Spondyloarthritis in Two Multicenter Cohorts of Patients with Psoriasis, Uveitis, and Colitis Presenting with Undiagnosed Back Pain

2024-8-6

Features associated with different inflammatory phenotypes of calcium pyrophosphate deposition (<scp>CPPD</scp>) disease: study using data from the international <scp>ACR</scp>/<scp>EULAR CPPD</scp> classification criteria cohort

2024-8-1

Reply letter

2024-8-1

Long‐term follow‐up of anti‐infliximab antibodies in radiographic axial spondyloarthritis patients: a marker of drug survival and tapering: comment on the article by Clarissa et al

2024-8-1

Patterns of Infliximab Biosimilar Uptake for Medicare, Medicaid, and Private Insurance from 2016 to 2022

2024-7-30

Journal Club

2024-7-30

Clinical Connections

2024-7-30

Diversity and Inclusivity in Rheumatology Publications

2024-7-30

Issue Information

2024-7-30